Odonate Therapeutics (OTC: ODT)
Odonate Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Odonate Therapeutics Company Info
Odonate, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improve and extend the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.
News & Analysis
Why Odonate Therapeutics Stock Is Crashing Today
The company's news was so bad that it's going out of business.
Why Odonate Therapeutics Stock Is Soaring Today
A couple of factors appear to be at work after the company announced the pricing of a secondary stock offering.
Here's Why Odonate Therapeutics Stock Jumped 70.7% in June
Purchases disclosed by a company insider boosted investor confidence and the company's chemotherapy pill.
3 Biotech Stocks That Soared This Week: Are They Buys?
Can the momentum continue for these hot biotech stocks?
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.